2023
DOI: 10.3389/fgene.2023.1052444
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders

Abstract: Background: Sickle cell disease (SCD) continues to pose physical and psychosocial burdens to patients, caregivers and health workers. Stakeholder engagement in the processes of policy making and implementation is increasingly becoming the cornerstone of best practices in healthcare.Aim and Objectives: To engage stakeholders with a view to assessing the knowledge of SCD; ascertain the challenges associated with accessibility and affordability of healthcare services; improve the quality of care, and thereby effe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…The accuracy, timeliness, and tone of media reports, as well as transparency in engaging with the media, are all critical, particularly in reporting serious adverse events. Initiatives such as SickleInAfrica have started exploring ways of engaging stakeholders in public health genetics [65] and this experience could be leveraged for SCD gene therapy research in Africa. Public engagement initiatives should see patient-participants as partners who have the agency to contribute to the implementation of SCD gene therapy trials.…”
Section: Public Engagement Patient Education and Counsellingmentioning
confidence: 99%
“…The accuracy, timeliness, and tone of media reports, as well as transparency in engaging with the media, are all critical, particularly in reporting serious adverse events. Initiatives such as SickleInAfrica have started exploring ways of engaging stakeholders in public health genetics [65] and this experience could be leveraged for SCD gene therapy research in Africa. Public engagement initiatives should see patient-participants as partners who have the agency to contribute to the implementation of SCD gene therapy trials.…”
Section: Public Engagement Patient Education and Counsellingmentioning
confidence: 99%